vs
Side-by-side financial comparison of Palomar Holdings, Inc. (PLMR) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $253.4M, roughly 1.2× Palomar Holdings, Inc.). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs -6.4%). Over the past eight quarters, Palomar Holdings, Inc.'s revenue compounded faster (46.2% CAGR vs 4.2%).
Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PLMR vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $253.4M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 28.7% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | 62.7% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $2.05 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $253.4M | $295.9M | ||
| Q3 25 | $244.7M | — | ||
| Q2 25 | $203.3M | $317.0M | ||
| Q1 25 | $174.6M | $316.2M | ||
| Q4 24 | $155.8M | $297.0M | ||
| Q3 24 | $148.5M | $289.5M | ||
| Q2 24 | $131.1M | $306.1M | ||
| Q1 24 | $118.5M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $51.5M | — | ||
| Q2 25 | $46.5M | $-17.7M | ||
| Q1 25 | $42.9M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $30.5M | $33.6M | ||
| Q2 24 | $25.7M | $40.6M | ||
| Q1 24 | $26.4M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 28.7% | 18.4% | ||
| Q3 25 | 27.4% | — | ||
| Q2 25 | 29.5% | -7.5% | ||
| Q1 25 | 30.8% | 12.2% | ||
| Q4 24 | 28.9% | 16.0% | ||
| Q3 24 | 25.9% | 13.8% | ||
| Q2 24 | 25.5% | 15.0% | ||
| Q1 24 | 29.0% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 21.0% | — | ||
| Q2 25 | 22.9% | -5.6% | ||
| Q1 25 | 24.6% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 20.5% | 11.6% | ||
| Q2 24 | 19.6% | 13.3% | ||
| Q1 24 | 22.3% | 16.2% |
| Q4 25 | $2.05 | $0.24 | ||
| Q3 25 | $1.87 | — | ||
| Q2 25 | $1.68 | $-0.11 | ||
| Q1 25 | $1.57 | $0.14 | ||
| Q4 24 | $1.29 | $0.22 | ||
| Q3 24 | $1.15 | $0.21 | ||
| Q2 24 | $1.00 | $0.26 | ||
| Q1 24 | $1.04 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $106.9M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $942.7M | $2.0B |
| Total Assets | $3.1B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $106.9M | $172.9M | ||
| Q3 25 | $111.7M | — | ||
| Q2 25 | $81.3M | $162.2M | ||
| Q1 25 | $119.3M | $140.7M | ||
| Q4 24 | $80.4M | $177.5M | ||
| Q3 24 | $86.5M | $187.5M | ||
| Q2 24 | $47.8M | $152.9M | ||
| Q1 24 | $61.4M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $942.7M | $2.0B | ||
| Q3 25 | $878.1M | — | ||
| Q2 25 | $847.2M | $1.9B | ||
| Q1 25 | $790.4M | $2.0B | ||
| Q4 24 | $729.0M | $2.1B | ||
| Q3 24 | $703.3M | $2.1B | ||
| Q2 24 | $532.6M | $2.1B | ||
| Q1 24 | $501.7M | $2.0B |
| Q4 25 | $3.1B | $2.5B | ||
| Q3 25 | $2.9B | — | ||
| Q2 25 | $2.8B | $2.6B | ||
| Q1 25 | $2.4B | $2.6B | ||
| Q4 24 | $2.3B | $2.7B | ||
| Q3 24 | $2.3B | $2.7B | ||
| Q2 24 | $2.0B | $2.7B | ||
| Q1 24 | $1.9B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $409.1M | — |
| Free Cash FlowOCF − Capex | $409.0M | — |
| FCF MarginFCF / Revenue | 161.4% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $700.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.1M | — | ||
| Q3 25 | $83.6M | — | ||
| Q2 25 | $120.9M | $98.2M | ||
| Q1 25 | $87.2M | $41.1M | ||
| Q4 24 | $261.2M | $84.3M | ||
| Q3 24 | $100.3M | $63.9M | ||
| Q2 24 | $55.1M | $75.5M | ||
| Q1 24 | $33.1M | $81.0M |
| Q4 25 | $409.0M | — | ||
| Q3 25 | $83.6M | — | ||
| Q2 25 | $120.8M | $93.3M | ||
| Q1 25 | $87.1M | $31.0M | ||
| Q4 24 | $260.9M | $77.5M | ||
| Q3 24 | $100.1M | $54.7M | ||
| Q2 24 | — | $57.5M | ||
| Q1 24 | — | $64.5M |
| Q4 25 | 161.4% | — | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 59.4% | 29.4% | ||
| Q1 25 | 49.9% | 9.8% | ||
| Q4 24 | 167.5% | 26.1% | ||
| Q3 24 | 67.4% | 18.9% | ||
| Q2 24 | — | 18.8% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 0.1% | 3.2% | ||
| Q2 24 | 0.0% | 5.9% | ||
| Q1 24 | 0.0% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 2.60× | — | ||
| Q1 25 | 2.03× | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 3.29× | 1.90× | ||
| Q2 24 | 2.14× | 1.86× | ||
| Q1 24 | 1.26× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLMR
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
